Section of Infectious Diseases, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Via L. Armanni 5, 80131, Naples, Italy.
Infection. 2020 Feb;48(1):7-17. doi: 10.1007/s15010-019-01345-y. Epub 2019 Jul 25.
Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer and a leading cause of cancer-related deaths worldwide. The major risk factors for HCC development are chronic liver disease and cirrhosis due to hepatitis B virus (HBV) and/or hepatitis C virus (HCV), alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), steatohepatitis, intake of aflatoxin-contaminated food, diabetes, and obesity.
In Western countries, the number of NASH-related HCC cases is increasing, that of HBV- or HCV-related cases is declining due to the wide application of HBV universal vaccination and the introduction of effective therapies against HBV and HCV infections, and that of alcohol-related cases remaining substantially unchanged. Nevertheless, the burden of HCC is expected to increase worldwide in the next few decades, due to the population growth and aging expected in coming years. Overall, the abovementioned changes and future variations in lifestyle and in the impact of environmental factors in Western countries and a decreasing exposure to dietary aflatoxins and improved socio-economic conditions in developing countries will create new HCC epidemiology in the next few decades.
A substantial further reduction in cases of HCC requires a wider application of universal HBV vaccination and effective treatment of HBV- and HCV-related chronic hepatitis and cirrhosis, more effective campaigns to favor correct dietary habits and reduce alcohol consumption and the intensification of studies on HCC pathogenesis for future optimized prevention strategies.
肝细胞癌(HCC)是最常见的肝癌形式,也是全球癌症相关死亡的主要原因。HCC 发展的主要危险因素是慢性肝脏疾病和由乙型肝炎病毒(HBV)和/或丙型肝炎病毒(HCV)引起的肝硬化、酒精性肝病、非酒精性脂肪性肝病(NAFLD)、脂肪性肝炎、摄入黄曲霉毒素污染的食物、糖尿病和肥胖。
在西方国家,与 NASH 相关的 HCC 病例数量正在增加,由于 HBV 普遍疫苗接种的广泛应用以及针对 HBV 和 HCV 感染的有效治疗方法的引入,HBV 或 HCV 相关病例的数量正在减少,而与酒精相关的病例数量基本保持不变。然而,由于未来几年预期的人口增长和老龄化,预计在未来几十年内,全球 HCC 的负担将会增加。总的来说,上述变化以及未来几十年西方国家生活方式和环境因素影响的变化以及发展中国家饮食黄曲霉毒素暴露减少和社会经济条件改善,将在未来几十年创造新的 HCC 流行病学。
要进一步大幅减少 HCC 病例,需要更广泛地应用 HBV 普遍疫苗接种和有效治疗 HBV 和 HCV 相关的慢性肝炎和肝硬化,更有效地开展促进正确饮食习惯和减少饮酒的运动,并加强 HCC 发病机制的研究,以制定未来的优化预防策略。